Antibiotic Protection
Antibiotic Protection - Related Videos
13:39
Antibiotic Susceptibility Testing: Epsilometer Tests to Determine MIC Values of Two Antibiotics and Evaluate Antibiotic Synergy
0 Views •
2023
Source: Anna Bläckberg1, Rolf Lood1 1 Department of Clinical Sciences Lund, Division of Infection Medicine, Biomedical Center, Lund University, 221 00 Lund Sweden Knowledge of the interactions between antibiotics and bacteria is important in understanding how microbes evolve antibiotic resistance. In 1928, Alexander Fleming discovered penicillin, an antibiotic that exerts its antibacterial function by interfering with cell wall regeneration (1). Other antibiotics with diverse mechanisms of...
10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
0 Views •
Cited by 2 •
2019
We describe a platform that utilizes a library of isogenic antibiotic resistant Escherichia coli for the dereplication of antibiotics. The identity of an antibiotic produced by bacteria or fungi can be deduced by the growth of E. coli expressing its respective resistance gene. This platform is economically effective and time-efficient.
01:45
Antibiotic Selection
0 Views •
2026
Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
01:27
Production of Antibiotics
0 Views •
2026
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
02:30
F Plasmid Transfer and Dual Antibiotic Selection in E. coli
0 Views •
2025
Source: Erdogan, F.,et al., Conjugative Mating Assays for Sequence-specific Analysis of Transfer Proteins Involved in Bacterial Conjugation. J. Vis. Exp. (2017)This video demonstrates the procedure for transferring an F plasmid from donor to recipient E. coli cells using a rescue plasmid and selecting transconjugants through dual antibiotic resistance. The process includes mixing bacterial cultures, incubation without shaking, disrupting mating pairs, and plating on selective media to confirm...
FAQs
Two protective routes act at different stages of antibiotic exposure. Reduced entry limits how much drug reaches the cell, whereas efflux pumps actively expel antibiotic that has entered. Distinguishing these mechanisms helps explain why an antibiotic may fail to reach an effective level inside the cell and identifies whether access or export is the principal barrier.
Protection can also arise after the antibiotic reaches its cellular target. Bacteria may alter that target so the drug no longer acts effectively, or chemically inactivate the compound itself. This distinction separates a change in the cell’s susceptibility site from destruction or modification of the antibiotic, clarifying the mechanism behind survival.
Biofilm-associated protection differs from a purely cell-intrinsic mechanism because the surrounding microbial community can limit penetration and slow growth. The overview also distinguishes inherited genetic resistance from temporary physiological adaptation and cooperation among community members. Considering these possibilities is important when survival persists without a single explanation at the individual-cell level.
An investigation can examine survival in relation to the main protective possibilities: restricted entry, active efflux, target alteration, chemical inactivation, and biofilm-associated growth. It can then ask whether the observed protection reflects genetic resistance, temporary adaptation, or community cooperation. This framework links the survival outcome to a plausible biological mechanism.
Antibiotic protection matters because treatment failure may reflect more than the drug’s intended activity. Cells can limit entry, remove the compound, change its target, inactivate it, or persist in a biofilm-associated state. Recognizing these alternatives helps resistance research move beyond a single explanation and supports efforts to develop improved therapies.
Studying these mechanisms can inform diagnostic methods by connecting a survival pattern with the underlying protective process. It can also guide antibiotic-resistance research and the development of improved therapies. In this way, investigation is useful not only for describing why bacteria survive exposure, but also for developing strategies to control persistent infections.